Sage Journals: Discover world-class research

Abstract

Omicron variants have become the dominant SARS-CoV-2 variants due to their increased transmissibility and immune-escape ability. An outbreak of the Omicron variant BA.5.1.3 occurred in August 2022 in Sanya, China. Studying Omicron variants can promote the understanding of them and further contribute to managing the SARS-CoV-2 prevalence. This retrospective study analyzed the data of 258 patients with asymptomatic or mild SARS-CoV-2 admitted to the First Cabin Hospital of Sanya, China, between August 14 and September 4, 2022. The 258 patients comprised 128 males and 130 females with a mean age of 36.6 years and mean length of medical observation (LMO) of 10.1 days. Multiple linear regression analysis indicated that LMO was positively and negatively associated with age (p = 0.036) and vaccination status (p = 0.004), respectively. A Cox proportional-hazards model revealed that age (hazard ratio [HR] = 0.99, p = 0.029) and vaccination (HR = 1.23, p = 0.023) were risk and protective factors for LMO, respectively. Causal mediation analysis indicated that vaccination suppressed the effect of prolonging LMO caused by increasing age. Recovery times became longer with increasing age, which could be counterbalanced by vaccination. The present results indicate that vaccination interventions, even those developed through inactivated approaches, can still provide protection against Omicron variants.

Get full access to this article

View all access options for this article.

References

Aranha

, Patel

, Bhor

, et al. Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: An approach to reduce the isolation period for COVID-19 patients. J Med Virol, 2021; 93(12):6794–6797; doi: 10.1002/jmv.27206.

Branche

, Rouphael

, Diemert

, et al. SARS-CoV-2 variant vaccine boosters trial: Preliminary analyses. Infect Dis (except HIV/AIDS), 2022; doi: 10.1101/2022.07.12.22277336.

Callaway

. What Omicron's BA.4 and BA.5 variants mean for the pandemic. Nature, 2022; 606(7916):848–849; doi: 10.1038/d41586-022-01730-y.

Cao

, Wang

, Li

, et al. A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the delta and omicron variants: A randomized, double-blinded clinical trial. Sci China Life Sci, 2022a;65(8):1677–1679; doi: 10.1007/s11427-022-2110-1.

Cao

, Yisimayi

, Jian

, et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by omicron infection. Nature, 2022b;608(7923):593–602; doi: 10.1038/s41586-022-04980-y.

Cheng

, Mok

, Li

, et al. Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection. J Clin Virol, 2022; 156:105273; doi: 10.1016/j.jcv.2022.105273.

Ding

, Chen

, Meng

, et al. Correlation and influencing factors analysis of the cycle threshold value in detection of novel coronavirus nucleic acid(omicron) and the negative conversion cycle in infected patients. J Diagn Concepts Pract, 2022; 21(2):169–173.

Fan

, Li

, Zhang

, et al. SARS-CoV-2 omicron variant: Recent progress and future perspectives. Signal Transduct Target Ther, 2022; 7(1):141; doi: 10.1038/s41392-022-00997-x.

Feng

, Hong

, Fan

, et al. Age and sex differences among mildly symptomatic and asymptomatic patients with omicron infection in 2022 in Shanghai, China. J Multidiscip Healthc, 2022; 15:1909–1919; doi: 10.2147/JMDH.S375724.

10.

Fernandes

, Inchakalody

, Merhi

, et al. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann Med, 2022; 54(1):524–540; doi: 10.1080/07853890.2022.2031274.

11.

González

, Olszevicki

, Gaiano

, et al. Effectiveness of BBIBP-CorV, BNT162b2 and MRNA-1273 vaccines against hospitalisations among children and adolescents during the omicron outbreak in Argentina: A retrospective cohort study. Lancet Reg Health Am, 2022; 13:100316; doi: 10.1016/j.lana.2022.100316.

12.

Hewins

, Richardson

, Rubino

, et al. Molecular mechanisms responsible for SARS-CoV-2 antibody waning and vaccine escape in omicron sublineages BA.4 and BA.5. J Infect Dev Ctries, 2022; 16(07):1122–1125; doi: 10.3855/jidc.17010.

13.

Huang

, Li

, Xie

, et al. Progress in research of 2019-nCoV Omicron variant. Zhonghua Liu Xing Bing Xue Za Zhi Zhonghua Liuxingbingxue Zazhi, 2022; 43(5):655–662; doi: 10.3760/cma.j.cn112338-20220121-00061.

14.

La Scola

, Le Bideau

, Andreani

, et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis, 2020; 39(6):1059–1061; doi: 10.1007/s10096-020-03913-9.

15.

, Mok

BWY

, Chen

, et al. Neutralization of severe acute respiratory syndrome coronavirus 2 omicron variant by sera from BNT162b2 or CoronaVac vaccine recipients. Clin Infect Dis, 2022; 75(1):e822–e826; doi: 10.1093/cid/ciab1041.

16.

MacKinnon

, Krull

, Lockwood

. Equivalence of the mediation, confounding and suppression effect. Prev Sci, 2000; 1(4):173–181; doi: 10.1023/A:1026595011371.

17.

MacKinnon

, Lamp

. A unification of mediator, confounder, and collider effects. Prev Sci, 2021; 22(8):1185–1193; doi: 10.1007/s11121-021-01268-x.

18.

Meo

, Meo

, Al-Jassir

, et al. Omicron SARS-CoV-2 new variant: Global prevalence and biological and clinical characteristics. Eur Rev Med Pharmacol Sci, 2021; 25(24):8012–8018; doi: 10.26355/eurrev_202112_27652.

19.

Rabaan

, Tirupathi

, Sule

, et al. Viral dynamics and real-time RT-PCR Ct values correlation with disease severity in COVID-19. Diagnostics, 2021; 11(6):1091; doi: 10.3390/diagnostics11061091.

20.

Ren

, Wen

, Fan

, et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell, 2021; 184(7):1895.e19–1913.e19; doi: 10.1016/j.cell.2021.01.053.

21.

Sales

. Review: Mediation Package in R. J Educ Behav Stat, 2017; 42(1):69–84; doi: 10.3102/1076998616670371.

22.

Shrestha

, Foster

, Rawlinson

, et al. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission. Rev Med Virol, 2022; 32(5):e2381; doi: 10.1002/rmv.2381.

23.

Silva-Valencia

, Soto-Becerra

, Escobar-Agreda

, et al. Relative vaccine effectiveness of the booster dose of COVID-19 vaccine for preventing death in individuals with a primary regimen based on the BBIBP-CorV, ChAdOx1-S, or BNT162b2 vaccines during the omicron wave in Peru: A nested case-control study using national population data. Vaccine, 2022; 40(45):6512–6519; doi: 10.1016/j.vaccine.2022.09.066.

24.

Skok

, Stelzl

, Trauner

, et al. Post-mortem viral dynamics and tropism in COVID-19 patients in correlation with organ damage. Virchows Arch, 2021; 478(2):343–353; doi: 10.1007/s00428-020-02903-8.

25.

Tan

, Benedict

SLH

, Chang

, et al. Clinical severity of COVID-19 with omicron variant predominance in relation to vaccination status, age, comorbidities—A single center in Selangor, Malaysia. Med J Malaysia, 2022; 77(5):558–563.

26.

Tom

, Mina

. To interpret the SARS-CoV-2 test, consider the cycle threshold value. Clin Infect Dis, 2020; 71(16):2252–2254; doi: 10.1093/cid/ciaa619.

27.

Wang

, Zhao

, Song

, et al. Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 omicron variant escape from neutralizing antibodies. Emerg Microbes Infect, 2022; 11(1):477–481; doi: 10.1080/22221751.2022.2030200.

28.

Wen

, Ye

. Analyses of mediating effects: The development of methods and models. Adv Psychol Sci, 2014; 22(5):731; doi: 10.3724/SP.J.1042.2014.00731.

29.

Wright

. Pornography and sexual behavior: Do sexual attitudes mediate or confound?. Commun Res, 2020; 47(3):451–475; doi: 10.1177/0093650218796363.

30.

Zeng

, Wu

, Pan

, et al. Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: Interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials. Lancet Infect Dis, 2022; 22(4):483–495; doi: 10.1016/S1473-3099(21)00681-2.

31.

Zhan

X-Y

, Li

, Hu

, et al. Elderly male with cardiovascular-related comorbidities has a higher rate of fatal outcomes: A retrospective study in 602 patients with coronavirus disease 2019. Front Cardiovasc Med, 2021; 8:680604; doi: 10.3389/fcvm.2021.680604.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.02 MB

0.00 MB

Epidemiologic Characteristics of SARS-CoV-2 Omicron BA.5.1.3 Variant and the Protection Provided By Inactivated Vaccination

Abstract

Get full access to this article

References

Supplementary Material